InsiderClue
Stocks · Health care · Services-Commercial Physical & Biological Research

Charles River Laboratories

CRL Clue Score46
United States Fiscal year ends December CIK 0001100682
$301.79 +1.27% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $301.79 −25.99% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue1,681.4Operating income237.6Net income154.8EPS, diluted3.23Fiscal year 2017Revenue1,857.6 +10.5%Operating income288.3Net income123.4 −20.3%EPS, diluted2.54 −21.4%Fiscal year 2018Revenue2,266.1 +22.0%Operating income331.4Net income226.4 +83.5%EPS, diluted4.62 +81.9%Fiscal year 2019Revenue2,621.2 +15.7%Operating income351.2Net income252.0 +11.3%EPS, diluted5.07 +9.7%Fiscal year 2020Revenue2,923.9 +11.5%Operating income432.7Net income364.3 +44.6%EPS, diluted7.20 +42.0%Fiscal year 2021Revenue3,540.2 +21.1%Operating income589.9Net income391.0 +7.3%EPS, diluted7.60 +5.6%Fiscal year 2022Revenue3,976.1 +12.3%Operating income651.0Net income486.2 +24.4%EPS, diluted9.48 +24.7%Fiscal year 2023Revenue4,129.4 +3.9%Operating income617.3Net income474.6 −2.4%EPS, diluted9.22 −2.7%Fiscal year 2024Revenue4,050.0 −1.9%Operating income227.3Net income22.2 −95.3%EPS, diluted0.20 −97.8%Fiscal year 2025Revenue4,015.4 −0.9%Operating income25.2Net income−144.3 −750.1%EPS, diluted−2.91 −1,555.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 1,681.4 1,857.6 2,266.1 2,621.2 2,923.9 3,540.2 3,976.1 4,129.4 4,050.0 4,015.4
Growth +10.5% +22.0% +15.7% +11.5% +21.1% +12.3% +3.9% −1.9% −0.9%
Operating income 237.6 288.3 331.4 351.2 432.7 589.9 651.0 617.3 227.3 25.2
Net income 154.8 123.4 226.4 252.0 364.3 391.0 486.2 474.6 22.2 −144.3
Growth −20.3% +83.5% +11.3% +44.6% +7.3% +24.4% −2.4% −95.3% −750.1%
EPS, diluted 3.23 2.54 4.62 5.07 7.20 7.60 9.48 9.22 0.20 −2.91
Growth −21.4% +81.9% +9.7% +42.0% +5.6% +24.7% −2.7% −97.8% −1,555.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin14.1%Net margin9.2%Free cash flow margin15.6%Fiscal year 2017Operating margin15.5%Net margin6.6%Free cash flow margin12.7%Fiscal year 2018Operating margin14.6%Net margin10.0%Free cash flow margin13.3%Fiscal year 2019Operating margin13.4%Net margin9.6%Free cash flow margin13.0%Fiscal year 2020Operating margin14.8%Net margin12.5%Free cash flow margin13.0%Fiscal year 2021Operating margin16.7%Net margin11.0%Free cash flow margin15.0%Fiscal year 2022Operating margin16.4%Net margin12.2%Free cash flow margin7.4%Fiscal year 2023Operating margin14.9%Net margin11.5%Free cash flow margin8.8%Fiscal year 2024Operating margin5.6%Net margin0.5%Free cash flow margin12.4%Fiscal year 2025Operating margin0.6%Net margin−3.6%Free cash flow margin12.9%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 14.1% 15.5% 14.6% 13.4% 14.8% 16.7% 16.4% 14.9% 5.6% 0.6%
Net margin 9.2% 6.6% 10.0% 9.6% 12.5% 11.0% 12.2% 11.5% 0.5% −3.6%
Free cash flow margin 15.6% 12.7% 13.3% 13.0% 13.0% 15.0% 7.4% 8.8% 12.4% 12.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow316.9Capital expenditure−55.3Free cash flow261.6Buybacks−12.3Fiscal year 2017Operating cash flow318.1Capital expenditure−82.4Free cash flow235.6 −9.9%Buybacks−106.9Fiscal year 2018Operating cash flow441.1Capital expenditure−140.1Free cash flow301.1 +27.8%Buybacks−13.8Fiscal year 2019Operating cash flow480.9Capital expenditure−140.5Free cash flow340.4 +13.1%Buybacks−18.1Fiscal year 2020Operating cash flow546.6Capital expenditure−166.6Free cash flow380.0 +11.6%Buybacks−24.0Fiscal year 2021Operating cash flow760.8Capital expenditure−228.8Free cash flow532.0 +40.0%Buybacks−40.7Fiscal year 2022Operating cash flow619.6Capital expenditure−324.7Free cash flow294.9 −44.6%Buybacks−38.7Fiscal year 2023Operating cash flow683.9Capital expenditure−318.5Free cash flow365.4 +23.9%Buybacks−24.2Fiscal year 2024Operating cash flow734.6Capital expenditure−233.0Free cash flow501.6 +37.3%Buybacks−119.2Fiscal year 2025Operating cash flow737.6Capital expenditure−219.2Free cash flow518.5 +3.4%Buybacks−360.7
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 316.9 318.1 441.1 480.9 546.6 760.8 619.6 683.9 734.6 737.6
Capital expenditure −55.3 −82.4 −140.1 −140.5 −166.6 −228.8 −324.7 −318.5 −233.0 −219.2
Free cash flow 261.6 235.6 301.1 340.4 380.0 532.0 294.9 365.4 501.6 518.5
Growth −9.9% +27.8% +13.1% +11.6% +40.0% −44.6% +23.9% +37.3% +3.4%
Buybacks −12.3 −106.9 −13.8 −18.1 −24.0 −40.7 −38.7 −24.2 −119.2 −360.7

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash117.6Total debt1,212.7Net cash (debt)−1,095.1Shareholders’ equity836.8Debt to equity1.45Fiscal year 2017Cash163.8Total debt1,120.5Net cash (debt)−956.7Shareholders’ equity1,045.1Debt to equity1.07Fiscal year 2018Cash195.4Total debt1,655.0Net cash (debt)−1,459.5Shareholders’ equity1,317.3Debt to equity1.26Fiscal year 2019Cash238.0Total debt35.5Net cash (debt)202.5Shareholders’ equity1,634.6Debt to equity0.02Fiscal year 2020Cash228.4Total debt47.2Net cash (debt)181.2Shareholders’ equity2,114.6Debt to equity0.02Fiscal year 2021Cash241.2Total debt0.1Net cash (debt)241.1Shareholders’ equity2,534.8Debt to equity0.00Fiscal year 2022Cash233.9Total debt1.3Net cash (debt)232.6Shareholders’ equity2,976.3Debt to equity0.00Fiscal year 2023Cash276.8Total debt3.2Net cash (debt)273.6Shareholders’ equity3,596.9Debt to equity0.00Fiscal year 2024Cash194.6Total debt0.2Net cash (debt)194.5Shareholders’ equity3,461.5Debt to equity0.00Fiscal year 2025Cash213.8Total debt0.2Net cash (debt)213.6Shareholders’ equity3,164.6Debt to equity0.00
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 117.6 163.8 195.4 238.0 228.4 241.2 233.9 276.8 194.6 213.8
Total debt 1,212.7 1,120.5 1,655.0 35.5 47.2 0.1 1.3 3.2 0.2 0.2
Net cash (debt) −1,095.1 −956.7 −1,459.5 202.5 181.2 241.1 232.6 273.6 194.5 213.6
Shareholders’ equity 836.8 1,045.1 1,317.3 1,634.6 2,114.6 2,534.8 2,976.3 3,596.9 3,461.5 3,164.6
Debt to equity 1.45 1.07 1.26 0.02 0.02 0.00 0.00 0.00 0.00 0.00

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 30 Dec 2017 FY2018 29 Dec 2018 FY2019 28 Dec 2019 FY2020 26 Dec 2020 FY2021 25 Dec 2021 FY2022 31 Dec 2022 FY2023 30 Dec 2023 FY2024 28 Dec 2024 FY2025 27 Dec 2025
Margins
14.1% 15.5% 14.6% 13.4% 14.8% 16.7% 16.4% 14.9% 5.6% 0.6%
13.3% 16.0% 12.4% 11.6% 15.3% 13.6% 15.7% 14.1% 2.3% −2.5%
9.2% 6.6% 10.0% 9.6% 12.5% 11.0% 12.2% 11.5% 0.5% −3.6%
15.6% 12.7% 13.3% 13.0% 13.0% 15.0% 7.4% 8.8% 12.4% 12.9%
Spending
21.7% 20.0% 19.6% 19.7% 18.1% 17.5% 16.7% 18.1% 18.5% 18.5%
3.3% 4.4% 6.2% 5.4% 5.7% 6.5% 8.2% 7.7% 5.8% 5.5%
30.0% 57.7% 19.3% 16.5% 18.3% 17.0% 20.9% 17.4% 72.8% n/a
Returns
18.5% 11.8% 17.2% 15.4% 17.2% 15.4% 16.3% 13.2% 0.6% −4.6%
5.7% 4.2% 5.9% 5.4% 6.6% 5.6% 6.4% 5.8% 0.3% −2.0%
Balance and payout
1.45 1.07 1.26 0.02 0.02 0.00 0.00 0.00 0.00 0.00
68.5% 63.7% 65.3% 64.5% 61.0% 63.1% 60.2% 55.4% 53.4% 55.0%
4.7% 45.4% 4.6% 5.3% 6.3% 7.7% 13.1% 6.6% 23.8% 69.6%